Earnings History Data for Teva Pharmaceutical Industries Limited (TEVA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Teva Pharmaceutical Industries Limited

TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-11-2024	PM		TEVA	Teva Pharmaceutical Industries Limited	21,120	0.67	0.63	0.58	Teva Pharmaceutical beats Q3 top and bottom line estimates, raises outlook [11/6/2024 7:03 AM]	17.46	-1.31 (-6.98%)	19.23	0.46 (2.45%)	8.55 - 19.31	16,718,211	5,900,000	181,899
Teva Pharmaceutical Q3 2024 Earnings Preview [11/5/2024 11:16 AM] Teva Pharmaceutical beats Q3 top and bottom line estimates, raises outlook [11/6/2024 7:03 AM] Teva gains after raising outlook for second time this year [11/6/2024 8:30 AM] Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS [2024-11-06 07:00AM]
31-07-2024	PM		TEVA	Teva Pharmaceutical Industries Limited	18,880	0.58	0.55	0.54	Teva Pharmaceutical beats Q2 estimates, raises outlook [7/31/2024 7:02 AM]	17.38	0.96 (5.88%)	17.30	0.89 (5.42%)	8.06 - 18.02	26,520,336	8,920,000	719,267
Teva Pharmaceutical Q2 2024 Earnings Preview [7/30/2024 12:28 PM] Teva Pharmaceutical beats Q2 estimates, raises outlook [7/31/2024 7:02 AM] Teva gains after lifting outlook on YTD performance [7/31/2024 8:15 AM]
08-05-2024	PM		TEVA	Teva Pharmaceutical Industries Limited	15,760	0.46	0.49	0.37	Teva Pharmaceutical reports mixed Q1 results; reaffirms FY24 outlook [5/8/2024 7:03 AM]	15.74	1.79 (12.83%)	15.74	0.0 (0.00%)	7.09 - 16.13	36,599,868	9,380,000	62,519
Teva, Medincell succeed in late-stage trial for injectable schizophrenia therapy [5/8/2024 7:40 AM] Teva Pharmaceutical reports mixed Q1 results; reaffirms FY24 outlook [5/8/2024 7:03 AM] Teva Pharmaceutical Q1 2024 Earnings Preview [5/7/2024 11:14 AM] Teva hits a five-year high on schizophrenia trial win, Q1 beat [5/8/2024 10:13 AM]
31-01-2024	PM		TEVA	Teva Pharmaceutical Industries	13,351	0.98	0.75	0.00	Teva Pharmaceutical Non-GAAP EPS of $1.00 beats by $0.24, revenue of $4.46B beats by $450M [1/31/2024 7:04 AM]	12.12	0.38 (3.28%)	11.76	0.03 (0.26%)	7.09 - 12.64	26,438,926	13,600,000	1,597,864
Teva earnings preview: Israeli drugmaker to report early Wednesday [1/30/2024 3:43 PM] Teva to divest API unit to focus on core business strengths [1/31/2024 6:25 AM] Teva Pharmaceutical Non-GAAP EPS of $1.00 beats by $0.24, revenue of $4.46B beats by $450M [1/31/2024 7:04 AM] Biggest stock movers today: Plug Power, Paramount Global, Google parent Alphabet, and more [1/31/2024 9:46 AM] Teva hits 52-week high on outlook, API divestment [1/31/2024 11:34 AM]
08-11-2023	PM		TEVA	Teva Pharmaceutical Industries Limited	10,140	0.58	0.57	0.56	Teva Pharmaceutical reports mixed Q3 earnings; reaffirms FY23 outlook [11/8/2023 7:03 AM]	9.15	0.11 (1.22%)	9.30	0.26 (2.88%)	7.09 - 11.44	10,988,268	7,330,000	1,192,650
Teva expected to report higher Q3 earnings, revenue early Wednesday [11/7/2023 6:23 PM] Teva appoints R. Ananth as CEO of Teva API division [11/7/2023 5:06 PM] Teva Pharmaceutical reports mixed Q3 earnings; reaffirms FY23 outlook [11/8/2023 7:03 AM] Teva lifts revenue guidance as generics drive Q3 beat [11/8/2023 8:15 AM] 6 stocks to watch on Wednesday: Teva, Roblox, Disney, Spirit AeroSystems and more [11/8/2023 9:04 AM]
02-08-2023	PM		TEVA	Teva Pharmaceutical Industries Limited	9,410	0.54	0.52	0.64	Teva Pharmaceutical beats Q2 top and bottom line estimates; raises FY23 revenue outlook [8/2/2023 7:03 AM]	9.28	0.99 (11.88%)	8.81	0.52 (6.27%)	7.09 - 11.44	29,733,293	10,720,000	1,914,118
Teva Pharmaceutical beats Q2 top and bottom line estimates; raises FY23 revenue outlook [8/2/2023 7:03 AM] Teva spikes after Q2 earnings beat and guidance raise [8/2/2023 7:59 AM] Teva estimates $200M impact from DOJ price fixing case [8/2/2023 10:26 AM] Biggest stock movers today: Teva Pharmaceutical, Lumen Technologies, XPeng and more [8/2/2023 10:25 AM] Teva CEO sees no value now in separating brands, generics businesses [8/2/2023 1:01 PM]
10-05-2023	PM	7:00 AM ET (May 10)	TEVA	Teva Pharmaceutical Industries Limited	10,150	0.37	0.55	0.53	Teva Pharmaceutical reports mixed Q1 earnings; reaffirms FY23 outlook [5/10/2023 7:02 AM]	8.31	-0.79 (-8.63%)	8.46	-0.64 (-7.03%)	6.78 - 11.44	23,847,223	7,130,000	1,177,471
Teva Pharmaceutical Q1 results in focus with eye on revenue numbers [5/9/2023 11:21 AM] Teva Pharmaceutical reports mixed Q1 earnings; reaffirms FY23 outlook [5/10/2023 7:02 AM] Teva reiterates outlook despite first revenue beat in two quarters [5/10/2023 7:39 AM] Hot Stocks: UPST, LI gain on strong earnings; CELH rise on an analyst upgrade; TWLO, TEVA, OXY slide [5/10/2023 1:40 PM]
08-02-2023	PM	7:00 AM ET (Feb 8)	TEVA	Teva Pharmaceutical Industries Limited	11,950	0.68	0.64	0.74	Teva Pharmaceutical reports Q4 earnings; initiates FY23 guidance [2/8/2023 7:02 AM]	9.95	-0.95 (-8.68%)	10.39	-0.50 (-4.59%)	6.78 - 11.44	18,071,907	7,890,000	626,743
Can Teva Pharmaceutical's Q4 results bring positive surprise? [2/7/2023 11:06 AM] Teva Pharmaceutical reports Q4 earnings; initiates FY23 guidance [2/8/2023 7:02 AM] Teva issues in line guidance as North American revenue remains flat [2/8/2023 7:53 AM]
03-11-2022	PM	7:00 AM ET (Nov 3)	TEVA	Teva Pharmaceutical Industries Limited	10,130	0.56	0.58	0.57	Teva Pharmaceutical Non-GAAP EPS of $0.59 misses by $0.03, revenue of $3.6B misses by $250M [11/3/2022 7:08 AM]	8.66	-0.10 (-1.14%)	8.18	-0.58 (-6.62%)	6.78 - 11.34	12,937,146	7,310,000	508,814
Teva Pharmaceutical Non-GAAP EPS of $0.59 misses by $0.03, revenue of $3.6B misses by $250M [11/3/2022 7:08 AM] Teva falls as FY22 outlook cut on forex woes, Q3 underwhelm estimates [11/3/2022 7:55 AM] Teva Pharmaceutical to pay New York $523M as part of opioid settlement [11/3/2022 12:46 PM] Drug, Biotech Stocks' Q3 Earnings on Nov 3: AMGN, REGN & More [Nov-02-22 09:25AM] Teva Reports Third Quarter 2022 Financial Results [Nov-03-22 07:00AM] Teva to pay up to $4.2 billion in U.S. to settle opioid claims [Nov-03-22 08:25AM]
03-05-2022	PM	7:00 AM ET (May 3)	TEVA	Teva Pharmaceutical Industries	9,875	0.53	0.55	0.00	Teva Pharmaceutical Non-GAAP EPS of $0.55 in-line, revenue of $3.7B misses by $50M [5/3/2022 7:01 AM]	8.63	0.11 (1.23%)	8.41	-0.12 (-1.41%)	7.24 - 11.54	9,626,979	7,430,000	741,362
Performance of generic drugs, opioid settlements in focus for Teva's Q1 earnings [5/2/2022 12:30 PM] Teva settles patent dispute with Lupin over Austedo [5/2/2022 8:49 AM] Teva Pharmaceutical Non-GAAP EPS of $0.55 in-line, revenue of $3.7B misses by $50M [5/3/2022 7:01 AM] Teva slips as forex impact prompts guidance cut [5/3/2022 8:05 AM] Drug/Biotech Stocks Q1 Earnings Due on May 3: PFE, BIIB & More [May-02-22 03:55PM] Teva Announces Settlement with Lupin Resolving AUSTEDO® (deutetrabenazine) Patent Dispute [May-02-22 08:00AM] Teva Reports First Quarter 2022 Financial Results [May-03-22 07:00AM] Teva shares slide 3% premarket as company swings to a loss and revenue falls [May-03-22 07:31AM] Tevas Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. [May-03-22 08:25AM] Why Generic Drugs Giant Teva Pharmaceutical Just Cut Its 2022 Outlook [May-03-22 09:44AM] UPDATE 2-Teva Pharm sees nationwide U.S. opioid settlement in 2022 [May-03-22 07:42AM] Teva Pharm sees nationwide U.S. opioid settlement in 2022 [May-03-22 07:11AM] Teva Pharmaceutical Industries (TEVA) Q1 2022 Earnings Call Transcript [May-03-22 11:00AM] Could Teva Join J&J, McKesson And Others In Settling Opioid Claims? [May-03-22 12:10PM] UPDATE 3-Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln [May-03-22 07:42AM] Teva Pharm expects U.S. opioid case settlements to cost $2.6 billion [May-03-22 07:11AM] Teva Posts Mixed Q1 Earnings, Cuts FY22 Sales Guidance Citing Copaxone Competition, Yet Shares Rise [May-03-22 10:36AM] Teva CEO Sees a Final Opioid Settlement Coming This Year [May-03-22 04:58PM]
09-02-2022	PM	7:00 AM ET (Feb 9)	TEVA	Teva Pharmaceutical Industries Limited	9,390	0.74	0.70	0.64	Teva Pharmaceutical Non-GAAP EPS of $0.77 beats by $0.04, revenue of $4.1B misses by $180M; initiates FY22 guidance [2/9/2022 7:03 AM]	8.98	0.69 (8.26%)	8.43	0.14 (1.69%)	7.73 - 13.30	25,906,115	7,880,000	774,325
Can Teva Pharmaceutical's Q4 results bring positive surprise? [2/8/2022 12:23 PM] Teva Pharmaceutical Non-GAAP EPS of $0.77 beats by $0.04, revenue of $4.1B misses by $180M; initiates FY22 guidance [2/9/2022 7:03 AM] Teva Q4 sales miss analyst forecasts amid COVID-19 impact; 2022 guidance disappoints [2/9/2022 7:47 AM] Opioid crisis: 'You can't put the genie back in the bottle' with the damage done, Harvard professor explains [Feb-08-22 03:22PM] Teva stock falls after revenue falls below expectations, full-year profit outlook misses [Feb-09-22 07:19AM] The Struggles Continue For Generic Drugs Behemoth Teva Pharmaceutical [Feb-09-22 08:57AM] The Struggles Continue For Generic Drug Behemoth Teva Pharmaceutical [Feb-09-22 10:08AM] Teva Pharm may pay as much as $3.6 billion in U.S. opioid settlement [Feb-09-22 08:02AM] UPDATE 2-Teva Pharm may pay as much as $3.6 billion in U.S. opioid settlement [Feb-09-22 07:40AM] Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement [Feb-09-22 08:02AM] UPDATE 3-Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement [Feb-09-22 07:40AM]
27-10-2021	PM	7:00 AM ET (Oct 27)	TEVA	Teva Pharmaceutical Industries Limited	11,170	0.57	0.63	0.56	Teva Pharmaceutical EPS misses by $0.06, misses on revenue [10/27/2021 7:03 AM]	8.94	-0.45 (-4.79%)	8.93	-0.01 (-0.11%)	8.24 - 13.30	20,724,427	7,400,000	84,292
Teva, MODAG to collaborate on candidate for Parkinson's, multiple system atrophy [10/26/2021 5:12 PM] Teva Pharmaceutical falls 6% on eve of Q3 earnings show [10/26/2021 12:13 PM] Teva Pharmaceutical EPS misses by $0.06, misses on revenue [10/27/2021 7:03 AM] Teva Pharmaceutical launches $4B in sustainability-linked senior notes offering, $3.5B debt tender offers for notes [10/27/2021 7:51 AM] Teva's Q3 results impacted by lower Copaxone, generic drugs sales [10/27/2021 8:02 AM] Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate [Oct-26-21 04:45PM] Teva Reports Third Quarter 2021 Financial Results [Oct-27-21 07:00AM] Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes [Oct-27-21 07:15AM] Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024 [Oct-27-21 07:15AM] Teva shares slump premarket after earnings fall short of estimates [Oct-27-21 07:29AM] Teva Earnings Miss Estimates. The Stock Is Falling. [Oct-27-21 08:49AM] Teva Stock Dips As The Sales Downfall Continues For Its Biggest Product [Oct-27-21 09:00AM] Teva Pharm unlikely to produce COVID vaccines, treatments, CEO says [Oct-27-21 09:42AM] Teva Stock Dives As The Sales Downfall Continues For Its Biggest Product [Oct-27-21 10:57AM] UPDATE 2-Teva Pharm Q3 profit misses estimates, sees recovery into Q4 [Oct-27-21 07:35AM] Teva Pharm Q3 profit misses estimates, sees recovery into Q4 [Oct-27-21 07:19AM] Teva Q3 Earnings Fall Short Of Expectations; Reaffirms FY21 Guidance [Oct-27-21 09:02AM] Teva CEO Says Hes Still Hoping For a Nationwide Opioid Settlement [Oct-27-21 01:01PM] Why Teva Pharmaceutical Industries Fell Today [Oct-27-21 06:01PM]
28-07-2021	PM	7:00 AM ET (Jul 28)	TEVA	Teva Pharmaceutical Industries Limited	9,860	0.57	0.56	0.52	Teva Pharmaceutical EPS in-line, misses on revenue, lwers FY21 guidance [7/28/2021 7:03 AM]	9.99	1.07 (12.00%)	9.99	0.0 (0.00%)	8.24 - 13.30	42,828,586	11,990,000	157,797
Teva Pharmaceutical Q2 2021 Earnings Preview [7/27/2021 12:38 PM] Teva Pharmaceutical EPS in-line, misses on revenue, lwers FY21 guidance [7/28/2021 7:03 AM] Teva Pharma drops 2% on Q2 top-line miss; lowered revenue guidance [7/28/2021 7:40 AM] Teva up 13% despite Q2 2021 revenue miss, downward revenue outlook [7/28/2021 1:14 PM] Teva Reports Second Quarter 2021 Financial Results [Jul-28-21 07:00AM] Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis [Jul-28-21 07:30AM] Teva revenue falls short of estimates, lowers guidance as pandemic continue to weigh [Jul-28-21 07:34AM] Teva Q2 profit up, sees lower sales for 2021 [Jul-28-21 08:18AM] UPDATE 2-Teva Q2 profit up, sees lower sales for 2021 [Jul-28-21 08:07AM] UPDATE 3-Teva profit rise misses forecasts, sees lower 2021 sales [Jul-28-21 08:07AM] Teva Stock Climbs After Earnings Match Estimates [Jul-28-21 07:44AM] Institutions Have Been Holding Back, but Teva Pharmaceutical Industries Limited (NYSE:TEVA) is Beginning to Stabilize [Jul-28-21 07:02AM] Teva Stock Climbs as CEO Says Opioid Settlement Could Come Within a Year [Jul-28-21 03:43PM]
28-04-2021	PM	7:00 AM ET (Apr 28)	TEVA	Teva Pharmaceutical Industries Limited	11,700	0.60	0.55	0.73	Teva Pharmaceutical EPS beats by $0.03, misses on revenue [4/28/2021 7:01 AM]	10.12	-0.25 (-2.41%)	10.28	-0.09 (-0.87%)	8.44 - 13.30	11,735,885	8,880,000	661,918
Teva Pharmaceutical Q1 2021 Earnings Preview [4/27/2021 12:34 PM] Teva Pharmaceutical EPS beats by $0.03, misses on revenue [4/28/2021 7:01 AM] Teva reaffirms 2021 guidance as Q1 revenue misses the consensus [4/28/2021 7:38 AM] Teva is unlikely to join COVID-19 vaccine production: CEO [4/28/2021 12:09 PM] Teva to Present New Analyses of AUSTEDO® (deutetrabenazine) Tablets and Assessment of Schizophrenia Clinical Outcomes at Upcoming 2021 American Psychiatric Association Annual Meeting [Apr-27-21 08:00AM] Teva Pharmaceutical Industries Ltd. to Host Earnings Call [Apr-28-21 06:15AM] Teva Reports First Quarter 2021 Financial Results [Apr-28-21 07:00AM] Teva Earnings Top But Drugmaker's Sales Just Miss Views [Apr-28-21 07:13AM] Teva's stock gains after it beats earnings expectations [Apr-28-21 07:40AM] UPDATE 1-Teva Pharm Q1 profit slips but Austedo sales keep rising [Apr-28-21 08:07AM] Teva Pharm Q1 profit slips but Austedo sales keep rising [Apr-28-21 07:29AM] Exclusive: Teva Pharm unlikely to reach deals to co-produce vaccines -CEO [Apr-28-21 10:10AM] What's Behind Teva's Mixed Q1 Results [Apr-28-21 10:55AM] Teva Pharma Stock Hits The Skids As Revenue Declines Again [Apr-28-21 11:11AM] UPDATE 2-New branded drugs helping Teva Pharm move closer to growth [Apr-28-21 08:07AM] New branded drugs helping Teva Pharm move closer to growth [Apr-28-21 07:29AM] Teva says vaccine makers have not taken its offer to help produce jabs [Apr-27-21 08:00PM] Teva Pharmaceutical Industries (TEVA) Q1 2021 Earnings Call Transcript [Apr-28-21 02:30PM] Teva Halts Search for Partners to Develop COVID-19 Vaccine [Apr-28-21 10:47AM] Teva Abandons Search to Make Covid-19 Vaccine for Partners [Apr-28-21 12:11PM]
10-02-2021	PM	7:00 AM ET (Feb 10)	TEVA	Teva Pharmaceutical Industries Limited	13,930	0.64	0.61	0.61	Teva Pharmaceutical EPS beats by $0.06, beats on revenue [2/10/2021 7:02 AM]	11.94	-0.86 (-6.75%)	13.21	0.40 (3.12%)	6.25 - 13.76	33,936,247	8,122,070	822,165
Teva Pharmaceutical EPS beats by $0.06, beats on revenue [2/10/2021 7:02 AM] Teva Pharmaceutical Q4 2020 Earnings Preview [2/9/2021 11:44 AM] Teva gains 3% on upbeat Q4 earnings; FY21 guidance in-line with consensus [2/10/2021 7:33 AM] Teva close to opioid settlement - CEO Kare Schultz [2/10/2021 9:08 AM] Teva Stock Climbs as Earnings Hint at Turnaround [Feb-10-21 09:31AM] TEVA Q4 Earnings & Sales Beat Estimates, Stock Rises [Feb-10-21 09:26AM] Recap: Teva Pharmaceutical Q4 Earnings [Feb-10-21 07:16AM] Teva Reports Fourth Quarter and Full Year 2020 Financial Results [Feb-10-21 07:00AM]
05-11-2020	PM	7:00 AM ET (Nov 5)	TEVA	Teva Pharmaceutical Industries Limited	9,730	0.56	0.56	0.56	Teva Pharmaceutical EPS in-line, misses on revenue [11/5/2020 7:02 AM]	8.61	-0.60 (-6.51%)	8.61	0.0 (0.00%)	6.25 - 13.76	18,882,093	7,334,684	59,788

05-08-2020	PM	7:00 AM ET (Aug 5)	TEVA	Teva Pharmaceutical Industries Limited	12,640	0.52	0.50	0.57	Teva Pharmaceutical EPS beats by $0.02, misses on revenue [8/5/2020 7:03 AM]	12.36	0.56 (4.70%)	12.46	0.66 (5.59%)	6.07 - 13.76	12,805,377	6,596,005	876,192